These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11104204)

  • 1. Response to levodopa challenge in Tourette syndrome.
    Black KJ; Mink JW
    Mov Disord; 2000 Nov; 15(6):1194-8. PubMed ID: 11104204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic modulation of response inhibition: an fMRI study.
    Hershey T; Black KJ; Hartlein J; Braver TS; Barch DM; Carl JL; Perlmutter JS
    Brain Res Cogn Brain Res; 2004 Aug; 20(3):438-48. PubMed ID: 15268921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid intravenous loading of levodopa for human research: clinical results.
    Black KJ; Carl JL; Hartlein JM; Warren SL; Hershey T; Perlmutter JS
    J Neurosci Methods; 2003 Jul; 127(1):19-29. PubMed ID: 12865145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Treatment with Extended-Release Carbidopa-Levodopa (IPX066) in Early and Advanced Parkinson's Disease: A 9-Month Open-Label Extension Trial.
    Waters CH; Nausieda P; Dzyak L; Spiegel J; Rudzinska M; Silver DE; Tsurkalenko ES; Kell S; Hsu A; Khanna S; Gupta S
    CNS Drugs; 2015 Apr; 29(4):341-50. PubMed ID: 25895021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.
    Nyholm D; Nilsson Remahl AI; Dizdar N; Constantinescu R; Holmberg B; Jansson R; Aquilonius SM; Askmark H
    Neurology; 2005 Jan; 64(2):216-23. PubMed ID: 15668416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption of orally disintegrating carbidopa-levodopa requires intact small bowel function.
    Iyer SS; Morgan JC; Sethi KD
    Neurology; 2005 Nov; 65(9):1507. PubMed ID: 16275853
    [No Abstract]   [Full Text] [Related]  

  • 7. [Application of levodopa/carbidopa intestinal gel in advanced Parkinson's disease].
    Toth A; Nagy H; Wacha J; Bereczki D; Takáts A
    Neuropsychopharmacol Hung; 2015 Dec; 17(4):191-6. PubMed ID: 26727723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical studies with levodopa/carbidopa intestinal gel].
    Klivényi P; Vécsei L
    Ideggyogy Sz; 2014 Jan; 67(1-2):5-8. PubMed ID: 24654442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous levodopa administration in humans based on a two-compartment kinetic model.
    Gordon M; Markham J; Hartlein JM; Koller JM; Loftin S; Black KJ
    J Neurosci Methods; 2007 Jan; 159(2):300-7. PubMed ID: 16934332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study.
    Stocchi F; Rascol O; Kieburtz K; Poewe W; Jankovic J; Tolosa E; Barone P; Lang AE; Olanow CW
    Ann Neurol; 2010 Jul; 68(1):18-27. PubMed ID: 20582993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive-pharmacologic functional magnetic resonance imaging in tourette syndrome: a pilot study.
    Hershey T; Black KJ; Hartlein JM; Barch DM; Braver TS; Carl JL; Perlmutter JS
    Biol Psychiatry; 2004 May; 55(9):916-25. PubMed ID: 15110735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial.
    Müller-Vahl KR; Schneider U; Prevedel H; Theloe K; Kolbe H; Daldrup T; Emrich HM
    J Clin Psychiatry; 2003 Apr; 64(4):459-65. PubMed ID: 12716250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of the restless legs syndrome with carbidopa/levodopa.
    Allen RP; Earley CJ
    Sleep; 1996 Apr; 19(3):205-13. PubMed ID: 8723377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute vs chronic effects of l-dopa on bladder function in patients with mild Parkinson disease.
    Brusa L; Petta F; Pisani A; Moschella V; Iani C; Stanzione P; Miano R; Finazzi-Agrò E
    Neurology; 2007 May; 68(18):1455-9. PubMed ID: 17470746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of increasing doses of levodopa on children with strabismic amblyopia.
    Procianoy E; Fuchs FD; Procianoy L; Procianoy F
    J AAPOS; 1999 Dec; 3(6):337-40. PubMed ID: 10613576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
    Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Optimization of use of levodopa in Parkinson's disease: role of levodopa-carbidopa-entacapone combination].
    Castro A; Valldeoriola F; Linazasoro G; Rodriguez-Oroz MC; Stochi F; Marin C; Rodriguez M; Vaamonde J; Jenner P; Alvarez L; Pavon N; Macias R; Luquin MR; Hernandez B; Grandas F; Gimenez-Roldan S; Tolosa E; Obeso JA
    Neurologia; 2005 May; 20(4):180-8. PubMed ID: 15891947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
    Parkinson Study Group
    JAMA; 2000 Oct; 284(15):1931-8. PubMed ID: 11035889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial.
    Müller-Vahl KR; Schneider U; Koblenz A; Jöbges M; Kolbe H; Daldrup T; Emrich HM
    Pharmacopsychiatry; 2002 Mar; 35(2):57-61. PubMed ID: 11951146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.